Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Carriage Rates in Resident Physicians

This study has been terminated.
(Minimal enrollment)
Sponsor:
Information provided by (Responsible Party):
Gary Kinasewitz, University of Oklahoma
ClinicalTrials.gov Identifier:
NCT00929435
First received: June 24, 2009
Last updated: April 5, 2012
Last verified: April 2012

June 24, 2009
April 5, 2012
June 2009
January 2012   (final data collection date for primary outcome measure)
To detect an increase in MRSA nasal carriage rate among newly appointed residents after 1 year of regular patient contact. [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00929435 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Carriage Rates in Resident Physicians
The Incidence of Methicillin Resistant Staphylococcus Aureus (MRSA) Nasal Carriage Among Resident Physicians

One hundred new residents will be recruited prior to the start of residency and followed prospectively for a year. Monthly nasal swabs will be performed to identify colonization with methicillin resistant staphylococcus aureus (MRSA).The proportion of study subjects colonized with MRSA at the end of 1 year will be calculated.

This is a prospective observational study looking at the incidence of MRSA colonization. New residents will be monitored every month with nasal swabs.We would like to elucidate factors responsible for MRSA colonization in healthcare workers.We would like to see if health care workers who are colonized spontaneously cleared MRSA and if there was any factors involved.

Nasal swabs will be plated on the spot by trained individuals and the plates then incubated for 48 hours. Plates will be read by microbiologist after incubation.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

All newly recruited residents will be eligible for enrollment.

MRSA Colonization
Not Provided
MRSA surveillance
Newly recruited resident physicians will be monitored for a year with nasal swabs monthly.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
30
January 2012
January 2012   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Study subjects will be newly appointed residents at the OU medical center

Exclusion Criteria:

  • Previous MRSA infection
  • Current use of mupirocin
Both
25 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00929435
14684
No
Gary Kinasewitz, University of Oklahoma
University of Oklahoma
Not Provided
Principal Investigator: Gary T Kinasewitz, MD University of Oklahoma
University of Oklahoma
April 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP